Results 101 to 110 of about 3,939 (188)

Boyden Chamber Assay to Study of Cell Migration Induced by Metalloprotease Cleaved-CD95L

open access: yes, 2017
International audienceCD95 receptor, also called Fas or Apo-1, is a member of the tumor necrosis factor receptors (TNF-R) superfamily (Itoh and Nagata, J Biol Chem 268:10932-10937, 1993).
Legembre, Patrick   +3 more
core   +1 more source

Die Rolle des CD95/CD95L-Systems bei der Aktivierung primärer humaner T-Lymphozyten [PDF]

open access: yes, 2010
Der Todesfaktor CD95L ist bekannt für seine Fähigkeit apoptotischen Zelltod in CD95-sensitiven Zellen zu induzieren. Es häufen sich jedoch seit einiger Zeit Hinweise auf zusätzliche anti-apoptotische Funktionen des CD95/CD95L-Systems in verschiedenen ...
Paulsen, Maren
core   +1 more source

Liquid Chromatography–High Resolution Mass Spectrometry Method to Study Sphingolipid Metabolism Changes in Response to CD95L

open access: yes, 2017
International audienceSphingolipids are sphingoid base-containing lipids, among which some metabolites behave as bioactive molecules in various biological processes, including cell death.
Bassam Badran   +19 more
core   +1 more source

Fas/FasL在宫颈癌组织中的表达及意义

open access: yesZhongguo shiyan zhenduanxue, 2011
肿瘤不仅是增殖和分化异常的疾病,同时也是凋亡异常的疾病,肿瘤常表现出细胞增生亢进及凋亡减少。Fas/FasL系统是凋亡相关基因[1,2]。Fas,又名CD95或APO-1,属于肿瘤坏死因子受体(TN-FR)和神经生长因子受体(NGFR)家族。人Fas基因定位于第10号染色体长臂2区(10q24.1),包含8个内含子和9个外显子。Fas配体(Fasl),又称CD95L,
张妍, 张文颖, 周玲, 王莉
doaj  

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

open access: yesNature Communications
Despite sharing >98% genomic similarity, humans are more likely to develop cancers than our closest living ancestors, the nonhuman primates. Here, we unexpectedly discover that, unlike chimpanzee and other primates, a critical embryonic development ...
Brice E. N. Wamba   +10 more
doaj   +1 more source

CD95/Fas ligand induced toxicity. [PDF]

open access: yesBiochem Soc Trans, 2023
Haluck-Kangas A, Peter ME.
europepmc   +1 more source

A simple and broadly applicable nanobody-based approach to generate potent TNFR agonists. [PDF]

open access: yesCell Death Dis
Lang I   +16 more
europepmc   +1 more source

CD95/Fas stoichiometry in future precision medicine. [PDF]

open access: yesCell Death Differ
Sica M, Roussel M, Legembre P.
europepmc   +1 more source

Home - About - Disclaimer - Privacy